Pepdox
Studies
Peptides
Calculator
Generalizability of the SURPASS-2 Trial and Effect of Tirzepatide on US Diabetes and Obesity Control. | Pepdox
Home
/
Search
/
PMID 35929468
Generalizability of the SURPASS-2 Trial and Effect of Tirzepatide on US Diabetes and Obesity Control.
Journal of the American Heart Association
2022
PMID: 35929468
View on PubMed
DOI: 10.1161/JAHA.122.026297
Tirzepatide
Authors
Chiu, Nicholas; Aggarwal, Rahul; Bhatt, Deepak L
Keywords
diabetes
generalizability
obesity
tirzepatide